AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis

por Kim, Dae Gyu, Choi, Yongseok, Lee, Yuno, Lim, Semi, Kong, Jiwon, Song, JaeHa, Roh, Younah, Harmalkar, Dipesh S., Lee, Kwanshik, Goo, Ja-il, Cho, Hye Young, Mushtaq, Ameeq Ul, Lee, Jihye, Park, Song Hwa, Kim, Doyeun, Min, Byung Soh, Lee, Kang Young, Jeon, Young Ho, Lee, Sunkyung, Lee, Kyeong, Kim, Sunghoon
Publicado 2022